Drug Dosing Tool: Intelence (U.S. Department of Veterans Affairs)

Intelence (etravirine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor

Nonnucleoside reverse transcriptase inhibitors prevent HIV from using an enzyme called reverse transcriptase to make copies of itself. These drugs are also known as NNRTIs, nonnucleosides or "nonnukes."

Approved adult dosing

two 100 mg tablets, twice a day after meals

Morning
Intelence
Evening
Intelence

Note: Intelence must be used with other anti-HIV medicines. It is intended for patients who are taking anti-HIV medicines but whose medicines are not controlling their HIV infection or whose virus is becoming resistant to treatment.

Notes on taking this medication

Take after a meal (do not take without food)
Intelence can interact with other drugs; consult your medical provider

Side effects

Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
Nausea
Intelence has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

Disclaimer:

This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist.

Drug Dosing Toolkit

Intelence (etravirine)

Approved adult dosing

Morning

Evening

Notes on taking this medication

Side effects

My doctor's instructions

Disclaimer:

ContentsScroll over drug name to see other names for the drug.